 Neoplasm Invasiveness
"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1983 | 0 | 1 | 1 | | 1985 | 0 | 2 | 2 | | 1986 | 0 | 3 | 3 | | 1989 | 0 | 2 | 2 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 4 | 4 | | 1993 | 0 | 7 | 7 | | 1994 | 0 | 5 | 5 | | 1995 | 0 | 5 | 5 | | 1996 | 0 | 3 | 3 | | 1997 | 0 | 3 | 3 | | 1998 | 1 | 4 | 5 | | 1999 | 1 | 5 | 6 | | 2000 | 0 | 8 | 8 | | 2001 | 0 | 7 | 7 | | 2002 | 1 | 1 | 2 | | 2003 | 2 | 5 | 7 | | 2004 | 6 | 6 | 12 | | 2005 | 0 | 9 | 9 | | 2006 | 0 | 11 | 11 | | 2007 | 5 | 11 | 16 | | 2008 | 1 | 15 | 16 | | 2009 | 3 | 9 | 12 | | 2010 | 1 | 13 | 14 | | 2011 | 1 | 15 | 16 | | 2012 | 0 | 22 | 22 | | 2013 | 2 | 16 | 18 | | 2014 | 1 | 21 | 22 | | 2015 | 0 | 28 | 28 | | 2016 | 0 | 14 | 14 | | 2017 | 1 | 13 | 14 | | 2018 | 3 | 15 | 18 | | 2019 | 1 | 14 | 15 | | 2020 | 0 | 11 | 11 | | 2021 | 1 | 8 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Ghantous Y, Omar M, Broner EC, Agrawal N, Pearson AT, Rosenberg AJ, Mishra V, Singh A, El-Naaj IA, Savage PA, Sidransky D, Marchionni L, Izumchenko E. A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma. Int J Cancer. 2022 02 01; 150(3):450-460.
-
Chao JL, Korzinkin M, Zhavoronkov A, Ozerov IV, Walker MT, Higgins K, Lingen MW, Izumchenko E, Savage PA. Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma. Cell Rep Med. 2021 09 21; 2(9):100399.
-
Lee YH, Lee MM, De Silva DM, Roy A, Wright CE, Wong TK, Costello R, Olaku O, Grubb RL, Agarwal PK, Apolo AB, Bottaro DP. Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS One. 2021; 16(7):e0241766.
-
Gu J, Polley EC, Boughey JC, Fazzio RT, Fatemi M, Alizad A. Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers. Ultrasound Med Biol. 2021 08; 47(8):2193-2201.
-
Whiteley AE, Price TT, Cantelli G, Sipkins DA. Leukaemia: a model metastatic disease. Nat Rev Cancer. 2021 07; 21(7):461-475.
-
Bellmunt J, Hussain M, Gschwend JE, Albers P, Oudard S, Castellano D, Daneshmand S, Nishiyama H, Majchrowicz M, Degaonkar V, Shi Y, Mariathasan S, Grivas P, Drakaki A, O'Donnell PH, Rosenberg JE, Geynisman DM, Petrylak DP, Hoffman-Censits J, Bedke J, Kalebasty AR, Zakharia Y, van der Heijden MS, Sternberg CN, Davarpanah NN, Powles T. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 04; 22(4):525-537.
-
Hartl DM, Zafereo ME, Kowalski LP, Randolph GW, Olsen KD, Fernandez-Alvarez V, Nixon IJ, Shaha AR, Angelos P, Shah JP, Ferlito A. Occlusion of the internal jugular vein in differentiated thyroid carcinoma: Causes and diagnosis. Eur J Surg Oncol. 2021 Jul; 47(7):1552-1557.
-
Kuhar HN, Shay A, Revenaugh PC, Stenson K, Tajudeen BA, Smith R, Gattuso P, Al-Khudari S. Cytopathologic assessment of gloves and instruments after major head and neck surgery. Am J Otolaryngol. 2021 May-Jun; 42(3):102876.
-
Bandini M, Ross JS, Raggi D, Gallina A, Colecchia M, Lucianò R, Giannatempo P, Farè E, Pederzoli F, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Deho' F, Ali SM, Madison R, Chung JH, Salonia A, Briganti A, Montorsi F, Necchi A. Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. J Natl Cancer Inst. 2021 01 04; 113(1):48-53.
-
Hu C, Polley EC, Yadav S, Lilyquist J, Shimelis H, Na J, Hart SN, Goldgar DE, Shah S, Pesaran T, Dolinsky JS, LaDuca H, Couch FJ. The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort. J Natl Cancer Inst. 2020 12 14; 112(12):1231-1241.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|